Various Products / Cancer Research

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
10-101-34 Thymosin alpha1 Acetate 3108.3 C129H215N33O55
A08001 Alarin (human) 2894.29 C127H205N43O35
A4507 Ac-α-benzyl-muramyl-Ala-D-Glu(Lys(trans-(3-nitrocinnamoyl))-NH2)-NH2 884.94
A5201 Antipain 604.71
B07018 (D-Phe6,Leu13-(R)-p-chloro-Phe14)-Bombesin (6-14) 1123.75
B07021 (Leu13-(R)-Leu14)-Bombesin 1587.85
C06019 Calcitonin N-Terminal Flanking Peptide, human, N-Procalcitonin 6220.8
C07006 Calpain Inhibitor IV 475.6 C26H41N3O5
C11015 Smac N7 Protein 725.9
C11029 Z-Asp-2,6-dichlorobenzoyloxymethylketone 454.3 C20H17Cl2NO7
C11060 Z-Asp(OMe)-Gln-Met-DL-Asp(OMe)-fluoromethylketone 685.73
C23001 CKS-17 1942.29 C87H148N26O24
C23002 CKS-17 (7-12) 732.92 C37H60N6O9
CAD-113 Endotrophin(mouse) 7876.94 C₃₄₅H₅₂₀N₉₂O₁₀₆S₇
CP01904 D-allo-Threonine 119.12 C4H9NO3
CP25619 H-L-Tyr(PO3H2)-OH 261,16 g/mole C9H12NO6P
CP26243 1-Methyl-4-nitro-2-(trichloroacetyl)-1H-pyrrole 271.49 C7H5Cl3N2O3
CP26945 Phenylac-Gln-OH 264.28 C13H16N2O4
CR00007 H-Pro-His-Cys-Lys-Arg-Met-OH 771 C31H54N12O7S2
CR00008 Edelfosine 523.73 C₂₇H₅₈NO₆P

With the increasing proportion of cancer in the world year by year, cancer has become the main cause of death and a major public health problem in the world. Anticancer peptides can destroy the structure of tumor cell membrane or inhibit the proliferation and migration of cancer cells and the formation of tumor blood vessels, almost no hemolysis and no damage to normal human cells, which has become a hot spot in the research of new anti-tumor drugs. Because of the need to constantly find new therapeutic drugs, especially those that can escape drug resistance, inhibit metastasis and have no other important side effects, anticancer peptides have become one of the goals of new research. Anticancer peptides are a new type of anticancer drugs with small molecular peptides, which kill cancer cells by destroying the structure of tumor cell membrane or inhibiting the proliferation and migration of cancer cells and the formation of tumor blood vessels, but have low toxicity to normal cells. It is a hot spot in the research of new anti-tumor drugs at present.

The sources of anticancer peptides

Conclusion

Cancer kills millions of people every year. As a traditional means of cancer treatment, chemotherapy has some defects, such as low selectivity, great side effects, and multi-drug resistance and so on. Compared with traditional chemotherapeutic drugs, peptides as anti-cancer compounds have high selectivity and low toxicity. The modification of anticancer peptides and the combination of anticancer peptides with traditional drugs can give better play to the effect of anticancer peptides, which will become an important direction of the development of anticancer peptides.

References

  1. McDonnell, L. A., Corthals, G. L., Willems, S. M., van Remoortere, A., van Zeijl, R. J., & Deelder, A. M. (2010). Peptide and protein imaging mass spectrometry in cancer research. Journal of proteomics, 73(10), 1921-1944.
  2. Hernandez, V. (2019). Developing a Technique Using Peptide and Dye Synthesis for Cancer Research.